Literature DB >> 24733028

A high normal ankle-brachial index is associated with proteinuria in a screened cohort of Japanese: the Okinawa Peripheral Arterial Disease Study.

Akio Ishida1, Megumi Nakachi-Miyagi, Kozen Kinjo, Kunitoshi Iseki, Yusuke Ohya.   

Abstract

OBJECTIVES: We hypothesized that ankle-brachial index (ABI) increased with age as a result of arterial stiffness, and decreased when flow-limiting atherosclerotic stenosis occurred in the lower limbs. As arterial stiffness is associated with proteinuria, we investigated the relationship between ABI and prevalence of proteinuria.
METHODS: A cross-sectional study of ABI and proteinuria with 13,193 participants aged 21-89 years (53% women) from health checkups between July 2003 and March 2010 was conducted. ABI was measured using the automatic oscillometric method, and stratified into four groups: ABI ≤ 0.9 (low); 0.9 < ABI <1.0 (borderline low); 1.0 ≤ ABI <1.2 (normal); and 1.2 ≤ ABI <1.4 (high normal).
RESULTS: In participants with ABI at least 1.0, ABI was positively correlated with SBP, pulse pressure, and brachial-ankle pulse wave velocity. In participants with ABI less than 1.0, all indices were negatively correlated with ABI. The prevalence of proteinuria, defined as ≥ 1+ by dipstick, was significantly higher in low (23%) and high normal ABI (10%) compared with borderline low (6%) and normal ABI (7%). In participants at least 60 years, proteinuria was significantly associated with only low ABI [odds ratio (OR) 3.22, 95% confidence interval 1.34-7.41] compared with normal ABI before and after multivariable adjustment. In participants less than 60 years, adjusted OR for proteinuria was only significantly associated with high normal ABI (OR 1.32, 95% confidence interval 1.01-1.74).
CONCLUSION: High normal ABI in younger participants may be a result of arterial stiffness and associated with proteinuria.

Entities:  

Mesh:

Year:  2014        PMID: 24733028     DOI: 10.1097/HJH.0000000000000196

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  5 in total

1.  Asia-Pacific Consensus Statement on the Management of Peripheral Artery Disease: A Report from the Asian Pacific Society of Atherosclerosis and Vascular Disease Asia-Pacific Peripheral Artery Disease Consensus Statement Project Committee.

Authors:  Maria Teresa B Abola; Jonathan Golledge; Tetsuro Miyata; Seung-Woon Rha; Bryan P Yan; Timothy C Dy; Marie Simonette V Ganzon; Pankaj Kumar Handa; Salim Harris; Jiang Zhisheng; Ramakrishna Pinjala; Peter Ashley Robless; Hiroyoshi Yokoi; Elaine B Alajar; April Ann Bermudez-Delos Santos; Elmer Jasper B Llanes; Gay Marjorie Obrado-Nabablit; Noemi S Pestaño; Felix Eduardo Punzalan; Bernadette Tumanan-Mendoza
Journal:  J Atheroscler Thromb       Date:  2020-07-04       Impact factor: 4.928

2.  Compliance Index, a Marker of Peripheral Arterial Stiffness, may Predict Renal Function Decline in Patients with Chronic Kidney Disease.

Authors:  Te-Hui Kuo; Deng-Chi Yang; Wei-Hung Lin; Chin-Chung Tseng; Ju-Yi Chen; Chin-Shan Ho; Meng-Fu Cheng; Wei-Chuan Tsai; Ming-Cheng Wang
Journal:  Int J Med Sci       Date:  2015-06-12       Impact factor: 3.738

3.  Ankle-Brachial Index is a Predictor of Future Incident Chronic Kidney Disease in a General Japanese Population.

Authors:  Hiroshi Sonoda; Koshi Nakamura; Akiko Tamakoshi
Journal:  J Atheroscler Thromb       Date:  2019-04-30       Impact factor: 4.928

4.  Relationships between dipstick proteinuria and risk of hearing impairment among Japanese workers: a prospective cohort study.

Authors:  Mitsumasa Umesawa; Mikako Hara; Toshimi Sairenchi; Masanori Nagao; Yasuo Haruyama; Gen Kobashi
Journal:  BMJ Open       Date:  2019-11-02       Impact factor: 2.692

5.  The high normal ankle brachial index is associated with left ventricular hypertrophy in hypertension patients among the Han Chinese.

Authors:  Jin Sun; Shuxia Wang; Man Li; Yongkang Su; Shouyuan Ma; Yan Zhang; Anhang Zhang; Shuang Cai; Bokai Cheng; Qiligeer Bao; Ping Zhu
Journal:  J Clin Hypertens (Greenwich)       Date:  2021-07-23       Impact factor: 3.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.